article thumbnail

Digital dilemma in UK’s life sciences job market

Pharmaceutical Technology

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

article thumbnail

ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery

Pharma Times

Both companies will facilitate career progression while advancing the life sciences industry

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Partnership to advance life science professionals in drug discovery 

Drug Discovery World

The European Laboratory Research & Innovation Group (ELRIG) UK has entered into a partnership with SRG to support the advancement of science professionals in their careers. Sanj Kumar, CEO, ELRIG UK, said: “ELRIG and SRG have a shared ambition to advance the careers of early-stage professionals in drug discovery.

article thumbnail

Trust and treatment: GenAI in life sciences in 2024

pharmaphorum

Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.

article thumbnail

Life Science Trends for 2024 – Xtalks Life Science Podcast Ep. 143

XTalks

In this episode, Ayesha talked about some of the trends in the life sciences to watch out for in 2024. Hear about the latest technologies and approaches that will help drive innovations in drug discovery, clinical research and medical device design this year.

article thumbnail

Exploring the Endocannabinoid System for Drug Development, Featuring Punit Dhillon, Chairman & CEO of Skye Bioscience – Xtalks Life Science Podcast Ep. 144

XTalks

Skye Bioscience is at the forefront of exploring the endocannabinoid system for drug development. Punit Dhillon, Chairman & CEO Skye Bioscience Punit brings two decades of experience as a leader and investor within the life sciences sector. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

article thumbnail

Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170

Bio Pharma Dive

Elsewhere, ICER is raising questions about a PTSD drug and BioMarin is cut jobs after a pipeline review. The parent of Novo Nordisk is acquiring 60% ownership of Single Use Support.